Stay updated on IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial
Sign up to get notified when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.

Latest updates to the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe Record History now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor update to the page metadata rather than substantive study information.SummaryDifference0.0%

- Check24 days agoChange DetectedThe revision in the history was updated to v3.6.2, replacing the previous v3.6.0. This indicates a small metadata update to the page's revision record.SummaryDifference0.0%

- Check38 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not seeking participants. A new revision label 'v3.6.0' is added and the previous 'v3.5.5' revision is deleted.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry v3.5.5 was added to the record history. The previous revision v3.5.4 was removed from the history.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision v3.5.4 was added to the history, replacing the previous v3.5.3.SummaryDifference0.0%

- Check81 days agoChange DetectedA new revision entry, v3.5.3, was added to the history to document an update, replacing the previous v3.5.2. This reflects an administrative update recorded in the page history.SummaryDifference0.0%

Stay in the know with updates to IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.